MedPath
NMPA Approval

Naloxone Hydrochloride for Injection

国药准字H20080629

August 9, 2023

Drug Information

注射用盐酸纳洛酮

注射剂

2.0mg

化学药品

August 9, 2023

Company Information

Applicant Company

山西省大同经济技术开发区第一医药园区

Manufacturing Company

山西省大同经济技术开发区第一医药园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸纳洛酮 - NMPA 批准文号 | MedPath